BE520204A - - Google Patents
Info
- Publication number
- BE520204A BE520204A BE520204DA BE520204A BE 520204 A BE520204 A BE 520204A BE 520204D A BE520204D A BE 520204DA BE 520204 A BE520204 A BE 520204A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- acid
- compounds
- product
- hydrazide
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 10
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N β-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 claims description 9
- 229940097043 Glucuronic Acid Drugs 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 230000002378 acidificating Effects 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 description 29
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 25
- QRXWMOHMRWLFEY-UHFFFAOYSA-N Isoniazid Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 13
- 230000001988 toxicity Effects 0.000 description 9
- 231100000419 toxicity Toxicity 0.000 description 9
- 229950002441 Glucurolactone Drugs 0.000 description 7
- UYUXSRADSPPKRZ-SKNVOMKLSA-N Glucuronolactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000002609 media Substances 0.000 description 6
- 201000008827 tuberculosis Diseases 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-Aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 3
- 241000304886 Bacilli Species 0.000 description 3
- 206010052804 Drug tolerance Diseases 0.000 description 3
- 229960005322 Streptomycin Drugs 0.000 description 3
- 229960004909 aminosalicylic acid Drugs 0.000 description 3
- 244000052616 bacterial pathogens Species 0.000 description 3
- 230000003385 bacteriostatic Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drugs Drugs 0.000 description 3
- 230000026781 habituation Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N Isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 150000007857 hydrazones Chemical class 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 230000003902 lesions Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000134719 Aspergillus tamarii Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000222451 Lentinus tigrinus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229940049954 Penicillin Drugs 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241001279813 Sepedonium Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229960000626 benzylpenicillin Drugs 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000003197 catalytic Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000005712 crystallization Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000001747 exhibiting Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 239000001963 growth media Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001575 pathological Effects 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- KFUSANSHCADHNJ-UHFFFAOYSA-N pyridine-3-carbohydrazide Chemical compound NNC(=O)C1=CC=CN=C1 KFUSANSHCADHNJ-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE520204A true BE520204A (de) |
Family
ID=156172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE520204D BE520204A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE520204A (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1135442B (de) * | 1960-09-13 | 1962-08-30 | Rotta Res Lab | Verfahren zur Herstellung eines Glucuronsaeuresalzes |
-
0
- BE BE520204D patent/BE520204A/fr unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1135442B (de) * | 1960-09-13 | 1962-08-30 | Rotta Res Lab | Verfahren zur Herstellung eines Glucuronsaeuresalzes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2464956A1 (fr) | Procede de production de 10-deazaminopterine et de ses derives 10-alkyliques, composes obtenus et composition pharmaceutique les contenant | |
| FR2593809A1 (fr) | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique | |
| CH646412A5 (fr) | Procede de preparation des produits hydrosolubles a base de (+)-catechine et compositions contenant ces produits. | |
| FR2557878A1 (fr) | Compose antibiotique, procede pour le preparer et compositions le contenant | |
| WO2001091696A2 (fr) | Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant | |
| FR2532843A1 (fr) | Composition pharmaceutique comprenant a titre de principe actif le phytol ou l'isophytol | |
| FR2722410A1 (fr) | Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique | |
| BE520204A (de) | ||
| LU83739A1 (fr) | Alpha-(3,4,5-trimethoxybenzoylthio)propionylglycine,son procede de preparation et compositions pharmaceutiques la contenant | |
| LU87161A1 (fr) | Compositions pharmaceutiques | |
| FR2502627A1 (fr) | Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent | |
| CH317300A (fr) | Procédé de préparation de composés à activité bactériostatique | |
| FR2499981A1 (fr) | Acides amino-2 halogenobenzoyl-3 methylphenylacetiques et leurs esters et sels utiles comme medicaments anti-inflammatoires et analgesiques | |
| BE882889A (fr) | Sel de lysine de l'acide meta-benzoyl-hydratropique, son procede de preparation et compositions pharmaceutiques en contenant | |
| CA2493074A1 (fr) | Elevation du taux d'heme oxygenase avec des derives de la rheine | |
| CA2669871A1 (fr) | Composition terpenique anti-microorganisme | |
| CH421100A (fr) | Procédé de préparation de composés organiques de l'aluminium | |
| EP0065907B1 (de) | ((Tetra- und Hexahydro-pyridyl-4)-2-äthyl)-3-indole und ihre Verwendung als Arzneimittel | |
| EP0833635A1 (de) | Neue verwendung von pyrrolderivaten | |
| LU81968A1 (fr) | Sels d'argent d'acide phosphanilique,leur procede de production,composition antibacterienne les contenant et leur application a l'inhibition de la croissance des bacteries | |
| FR2491471A1 (fr) | Benzoxazolinones substituees, leur preparation et leur application en therapeutique | |
| BE875451A (fr) | Nouveaux medicaments constitues de derives de l'acide p-amino-benzoique | |
| FR2933300A1 (fr) | Compositions comprenant au moins une lignane et/ou neolignane en association avec un compose actif contre l'acne | |
| FR2458550A1 (fr) | Nouveaux derives du tetrahydropyridinyl-indole, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant | |
| FR2563520A1 (fr) | Nouveaux derives d'apovincaminol, procede pour leur preparation et compositions pharmaceutiques les contenant |